Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$13.32 - $19.19 $66,600 - $95,950
5,000 New
5,000 $88,000
Q4 2023

Feb 12, 2024

BUY
$6.68 - $18.81 $6,680 - $18,810
1,000 New
1,000 $17,000
Q2 2023

Aug 11, 2023

BUY
$15.48 - $35.0 $54,180 - $122,500
3,500 New
3,500 $86,000
Q1 2021

May 14, 2021

BUY
$41.61 - $54.3 $41,610 - $54,300
1,000 Added 33.33%
4,000 $192,000
Q3 2020

Nov 12, 2020

SELL
$18.49 - $27.24 $129,429 - $190,680
-7,000 Reduced 70.0%
3,000 $80,000
Q2 2020

Aug 14, 2020

BUY
$8.9 - $21.84 $35,600 - $87,360
4,000 Added 66.67%
10,000 $195,000
Q2 2019

Aug 13, 2019

BUY
$6.27 - $8.65 $25,080 - $34,600
4,000 Added 200.0%
6,000 $52,000
Q1 2019

May 15, 2019

BUY
$4.02 - $8.04 $8,039 - $16,079
2,000 New
2,000 $16,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.29B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.